Full time or Part time, Camperdown (Sydney)

Melanoma Institute Australia (MIA) is an independent, non-profit organisation with its head office located near North Sydney. We are the world’s largest treatment and research centre with a single focus on melanoma, and our mission is to reach zero deaths from melanoma this decade.

The Personalised Immunotherapy Program (PIP) is a 5 year program which aims to test cancer patients tumour biopsies for the presence of immune cells and immunotherapy drug targets. This data is used by the PIP team to make predictions around the likelihood of the patient to respond to anti-cancer immunotherapies. Immunohistochemical staining and analysis is performed on a weekly basis as patients are enrolled into the study.

The PIP team is looking for a histology scientist to perform immunohistochemical staining on a Leica Bond Rx system, whole slide scanning and to assist the team in performing quantitative image analysis on stained cancer tissue sections. The role will be responsible for the initial implementation of the workflows for histology block tracking, sectioning, staining, imaging and quality controls of patient samples to enable the PIP team to deliver accurate and reproducible results back to the clinical pathology and oncology teams.

The successful applicant will form part of the Translational Research Laboratory of the Melanoma Institute Australia, based at The University of Sydney Camperdown campus. They will work alongside our oncology, surgical, pathology and translational research teams. Within this team they would form part of the Personalised Immunotherapy Program (PIP) which aims to ensure each patient’s cancer is screened for genetic, transcriptomic and immune profiles to identify patients unlikely to benefit from standard therapies. These patients will then be assigned a novel clinical trial agent most likely to cure them based on the presence of the drug targets in the patient’s tumour. It is anticipated that selecting treatments for patients, based on the presence of specific drug targets in the patient’s cancer, will improve cancer outcomes of cancer patients. Full and part-time roles will be considered. Applications that do not address the selection criteria will not be processed.

Skills, Knowledge & Experience

• Technical experience, diploma, or bachelor’s degree in clinical immunohistology.

• Experience in performing immunohistochemical staining on an automated system.

• Preferably experience working on the Bond Leica systems.

• Preferably experience in multiplex immunohistochemistry.

• Excellent project management skills.

• Meticulous attention to detail and accuracy of results.

This is a unique opportunity to join a globally recognised research institute. You will also find immense satisfaction in joining a team which is making a very real difference to thousands of Australians, now and in the future.

Only applicants with full working rights within Australia should apply. Only successful applicants will be contacted. Please no recruitment agencies.

Role may be open until 11/6/22 unless a suitable candidate is found before.

As this role is based in a medical facility, applicants will need to be fully vaccinated against Covid-19.

If you have the right experience for this role, please provide a covering letter with your resume, addressing your experience in relation to the key responsibilities. Please email via the link below.

Please send your resume and cover letter using the link below.

Apply Now

We pay our respects to the Traditional Custodians of the lands on which Melanoma Institute Australia works, and their Elders both past and present, and acknowledge the deep, continuing connection of Aboriginal and Torres Strait Islander peoples to the land, waters, and sky.